Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Eleveld PK/PD Model-based Dosing vs Standard Dosing of Remimazolam During General Anesthesia
NCT07675850Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Eye-Opening Time. Started Jul 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT07675850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675850.